SavedAdd your journal

Journals / Clinical and Experimental Ocular Trauma and Infection / 2026 / Volume: 3 Issue: 1

Increasing cases of Orbital Mucormycosis in recent years

Halit Oğuz(İstanbul Medeniyet University)0000-0002-0983-5878
Ömer Yılmaz(Göztepe Prof. Dr. Süleyman Yalçın City Hopital,)0000-0001-5571-3735
Pages
—
Publication Date
2021-04-23
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Ophthalmologists should be aware of the possible vision threatening complications.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Mucormycosis is a uncommon but aggressive and lethal fungal infection, which can rapidly spread especially in immunosuppressed patients.
📊
Key Findings & Data:In recent years, there has been a serious increase in the number of orbital mucormycosis cases and publications.
💡
Conclusion & Impact:Ophthalmologists should be aware of the possible vision threatening complications.
🔬Design:Letter to Editor
📍Scope:Comprehensive Sample
⚙️Variables:mucormycosis · covid19 · pandemic

Abstract

Mucormycosis is a uncommon but aggressive and lethal fungal infection, which can rapidly spread especially in immunosuppressed patients. In recent years, there has been a serious increase in the number of orbital mucormycosis cases and publications. Mucormycosis prevalence in India is approximately 70 times more than the prevalence in developed countries. Diabetes mellitus, immunosuppression and trauma are major risk factors. Recently, COVİD-19 disease is common. COVID-19 infection and its treatment lead to immunosuppression, this has made patients vulnerable to secondary infections, including mucormycosis. Ophthalmologists should be aware of the possible vision threatening complications.

🔖

Cite This Article

Oğuz, H., Yılmaz, Ö. (2021). Increasing cases of Orbital Mucormycosis in recent years. Clinical and Experimental Ocular Trauma and Infection, Volume: 3 Issue: 1. https://ajindex.com/articles/1582551

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. Prakash H, Chakrabarti A. Epidemiology of Mucormycosis in India. Microorganisms. 2021;9(3):523.
  2. Dadhich A, Nilesh K, Patil R, Saluja H. Unusual presentation of mucormycosis mimicking a localised sino-orbital pathology. BMJ Case Rep. 2021;14(1).
  3. Sarkar S, Gokhale T, Choudhury SS, Deb AK. COVID-19 and orbital mucormycosis. Indian J Ophthalmol. 2021;69(4):1002-4.
  4. Veisi A, Bagheri A, Eshaghi M, Rikhtehgar MH, Rezaei Kanavi M, Farjad R. Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report. Eur J Ophthalmol. 2021;10(4)
  5. Mtibaa L, Halwani C, Tbini M, et al. Successful treatment of rhino-facial mucormycosis in a diabetic patient. Med Mycol Case Rep. 2020;27:64-7.